化学药品,原料+制剂(3.1+3.1类)。 [药品情况] 剂型及规格:舌下片:5mg。 [适应症] 治疗成人的急性精神分裂症。 [项目简介] 马来酸阿塞那平(Asenapine),商品名为Saphris,由Organon BioSciences公司研发、ScheringPlough公司生产。2009年8月14日FDA批准该药用于成年人精神分裂症 ...
Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...
Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...
The joint venture will comprise Future Generali India Insurance Company Ltd (FGIICL) and Future Generali India Life Insurance Company Ltd (FGILICL).